We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Why Have Multiple Sclerosis Drug Costs Tripled in Seven Years?

News   Jan 17, 2020 | Original story from the American Academy of Neurology

 
Why Have Multiple Sclerosis Drug Costs Tripled in Seven Years?
 
 
 

RELATED ARTICLES

Mouse Study Proposals Promising Parkinson's Molecule

News

A promising molecule has offered hope for a new treatment that could stop or slow Parkinson's. Researchers have found that molecule BT13 has the potential to both boost levels of dopamine, the chemical that is lost in Parkinson's, as well as protect the dopamine-producing brain cells from dying.

READ MORE

Why Social Media Can Make a Bad Breakup Worse

News

A new study from the University of Colorado Boulder has highlighted how social media has made the act of getting distance from a bad breakup that much harder.

READ MORE

Brain and Brawn: Hitting the Gym Slows Neurodegeneration in Older People At Risk of Alzheimer's

News

For the first time, an intervention - lifting weights - has been able to slow and even halt degeneration, over a long period, in brain areas particularly vulnerable to Alzheimer's disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE